Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.28 -0.57 (-1.91%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Gross Margin (2022 - 2024)

Updated

Amylyx Pharmaceuticals' Gross Margin was 93.19% in FY2024, down 0.13 percentage points from 93.32% in FY2023.

Analysis

Amylyx Pharmaceuticals (AMLX) Gross Margin (2022 - 2024) Analysis & Trends

  • Per Business Quant data, Gross Margin in earlier years was 93.32% in FY2023 (+6.78 pp) and 86.54% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Amylyx Pharmaceuticals 3.32 Bn 3.32 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 100.00%
Jun 30, 2024 99.22%
Mar 31, 2024 93.29%
Dec 31, 2023 91.37%
Sep 30, 2023 94.92%
Jun 30, 2023 94.32%
Mar 31, 2023 92.60%
Dec 31, 2022 87.11%
Sep 30, 2022 50.14%
API Access

Amylyx Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=AMLX&period=max&api_key=YOUR_API_KEY